SecBot SecBot
SC 13G/A ·Filed Oct 27, 2026

PFSA

Profusa, Inc.
NEUTRAL
Impact 2/10
Processed2h 56m ago SEC0001753926-26-002014
Passive stake amendment

Price Chart

Loading chart...

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001753926-26-002014
Document: 0001753926-26-002014-index.html0001753926-26-002014
Document: 0001753926-26-002014.txt0001753926-26-002014
20 reports for PFSA
Performance horizon
67% Hit rate @ T+5 6 of 9 directional calls Went positive at some point 7 of 9 best @ T+20▲ +74.77%Aug 20, 2026
Filters
Rows
Reports for PFSA — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 2/10
$0.7650awaiting T+5—$0.7800 (+1.96%)
Oct 15, 2026
12d ago
Press Release
NEUTRAL ★ 4/10
$1.07 $1.02▼ −4.67%▼ −3.66%$0.7800 (−27.10%)
Oct 15, 2026
12d ago
8-K
BEARISH ★ 6/10
$1.07 $1.02▲ +4.67%▲ +3.66%$0.7800 (+27.10%)
Oct 9, 2026
18d ago
8-K
BEARISH ★ 7/10
$1.30 $0.9002▲ +30.75%▲ +29.26%$0.7800 (+40.00%)
Oct 5, 2026
22d ago
8-K
NEUTRAL ★ 5/10
$1.75 $1.30▼ −25.71%▼ −26.14%$0.7800 (−55.43%)
Sep 24, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$3.03 $1.87▼ −38.28%▼ −37.87%$0.7800 (−74.26%)
Sep 16, 2026
5w ago
8-K
BEARISH ★ 6/10
$1.78 $2.05▼ −15.17%▼ −12.61%$0.7800 (+56.18%)
Sep 15, 2026
6w ago
8-K
BULLISH ★ 6/10
$1.83 $1.91▲ +4.37%▲ +3.55%$0.7800 (−57.38%)
Sep 1, 2026
8w ago
8-K
BEARISH ★ 6/10
$2.88 $2.47▲ +14.24%▲ +14.32%$0.7800 (+72.92%)
Aug 31, 2026
8w ago
8-K
BULLISH ★ 6/10
$3.00 $2.88▼ −4.00%▼ −3.86%$0.7800 (−74.00%)
Showing 10 of 20

US Market Status

Market Closed — Opens Thu (12h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh PFSA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access